Semotiadil — CAS 127779-20-8

Semotiadil is a high-purity Active Pharmaceutical Ingredient (API) classified as a Calcium Channel Blocker and Antiarrhythmic Agent. Mediocon Inc manufactures GMP-compliant Semotiadil at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide with consistent quality and full regulatory documentation. The compound exhibits selective action on cardiac and vascular smooth muscle calcium channels, making it valuable in cardiovascular therapeutic formulations.

• Cardiac arrhythmia management and antiarrhythmic therapy
• Calcium channel blockade in cardiovascular conditions
• Angina pectoris and ischaemic heart disease
• Hypertension adjunct therapy via vascular smooth muscle relaxation

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support